From: <[log in to unmask]>
Date: Wed, 7 Aug 2013 10:53:11 +0000
***This was also posted to MED-LIB***
Dear all,
Below is the press release about a new service from Faculty of 1000,
F1000Trials.
The release is also online here:
http://f1000.com/resources/F1000Trials_Launch_PR.pdf
and a blog entry outlines some of the features of the service:
http://blog.f1000.com/2013/08/06/f1000trials-beta-launch/
Best regards,
Iain
*******
PRESS RELEASE:
Making it less of a trial to find important medical evidence: Faculty
of 1000 launch F1000Trials
Faculty of 1000, the publisher of a range of services for life
scientists and clinicians, today launches an innovative new product,
F1000Trials (http://f1000.com/trials), designed to enable rapid
discovery and understanding of articles about clinical trials.
F1000Trials is a continually updated, comprehensive database of
articles on randomized controlled trials and systematic reviews, drawn
from more than 300 key general and specialist medical journals.
As randomized controlled trials and systematic reviews in healthcare
have grown in their number and influence, there is an increasing need
to identify those studies which should change how physicians treat
their patients - and those which should not. F1000Trials extends the
widely-recognized system of peer-nominated experts identifying great
research in biology and medicine pioneered by F1000Prime
(http://f1000.com/prime). In F1000Trials, the F1000 Faculty Members
provide expert assessment of newly published trial articles and write
short reviews, recommending the most noteworthy by assigning star
ratings and highlighting those which change clinical practice.
Faculty of 1000 Managing Director Anne Greenwood said: "There is an
increasing amount of information about clinical trials being shared
online but it can be difficult to search, compare, and understand.
F1000Trials will help many different users of the medical literature -
including practicing clinicians, clinical researchers, health policy
makers, librarians, pharmacists, regulators, patient organizations and
the pharmaceutical industry - to easily find out which clinical trials
matter most and where all the key publications can be found."
Clinical trials can produce numerous publications about the same
trial, scattered and disconnected across different journals and
databases. F1000Trials makes it easier to find clinical trials by
providing links to all publications known about a particular trial
that are included in the largest bibliographic life science database,
PubMed. Links to trial registration databases are also included,
helping to create an electronic "threaded publication trail" about
clinical trials.
Prof Peter Sandercock, University of Edinburgh, said: "I'm delighted
that F1000 will, by linking and alerting us to new trial publications,
contribute to greater transparency and efficiency in reporting and
disseminating results of trials. This alerting mechanism will also
facilitate prompt updating of systematic reviews of trials."
F1000Trials provides a powerful search engine, allowing users to
search instantly across all known generic names and brand names of
particular drugs, as well as search for specific studies, diseases and
conditions. F1000Trials identifies and tags articles that report
negative or null results - important studies for providing complete
medical evidence, which can be difficult to identify with current
literature searching tools.
Speaking of the launch of F1000Trials, award-winning writer and
researcher Dr Ben Goldacre said: "We urgently need more transparency
around clinical trial results, to avoid negative results being
withheld. But we also need more engagement by clinicians and the
public with all trials research. Tools like F1000Trials are an
important part of that movement, away from the bad old days of trial
results being entirely inaccessible, or - almost as bad - sitting in
long technical documents, that busy clinicians may not have time to
read."
F1000Trials is currently in its public "beta" phase, and is free to
access to anyone who registers on the website. Faculty of 1000 invites
all people interested in improving how we access and communicate
information about clinical trials to try out F1000Trials and send
their feedback.
..............
About Faculty of 1000 (F1000)
Faculty of 1000 is the publisher of four unique services that support
and inform the work of life scientists and clinicians. F1000Prime and
F1000Trials provide a layer of expert opinion and guidance on
published articles, and F1000Research and F1000Posters present
original and useful work via open access websites that encourage
transparency, sharing and debate. Members of F1000's executive team
have helped to create and launch many successful online scientific
resources, including the world's first Open Access publisher - BioMed
Central.
To find out more about Faculty of 1000 and F1000Trials, please contact
Iain Hrynaszkiewicz on +44 (0)20 7079 4888 or email [log in to unmask]
For more information, visit http://f1000.com
Iain Hrynaszkiewicz
Outreach Director
FACULTY of 1000
http://f1000.com
Email: [log in to unmask]
|
